收费全文 | 21576篇 |
免费 | 1699篇 |
国内免费 | 236篇 |
耳鼻咽喉 | 460篇 |
儿科学 | 385篇 |
妇产科学 | 338篇 |
基础医学 | 3344篇 |
口腔科学 | 368篇 |
临床医学 | 1992篇 |
内科学 | 4517篇 |
皮肤病学 | 480篇 |
神经病学 | 1648篇 |
特种医学 | 1342篇 |
外科学 | 3068篇 |
综合类 | 254篇 |
现状与发展 | 1篇 |
一般理论 | 9篇 |
预防医学 | 1453篇 |
眼科学 | 584篇 |
药学 | 1542篇 |
1篇 | |
中国医学 | 194篇 |
肿瘤学 | 1531篇 |
2023年 | 124篇 |
2022年 | 414篇 |
2021年 | 714篇 |
2020年 | 334篇 |
2019年 | 526篇 |
2018年 | 584篇 |
2017年 | 472篇 |
2016年 | 658篇 |
2015年 | 869篇 |
2014年 | 1020篇 |
2013年 | 1268篇 |
2012年 | 1775篇 |
2011年 | 1643篇 |
2010年 | 1097篇 |
2009年 | 928篇 |
2008年 | 1287篇 |
2007年 | 1137篇 |
2006年 | 1042篇 |
2005年 | 908篇 |
2004年 | 767篇 |
2003年 | 643篇 |
2002年 | 655篇 |
2001年 | 327篇 |
2000年 | 312篇 |
1999年 | 268篇 |
1998年 | 133篇 |
1997年 | 117篇 |
1996年 | 87篇 |
1995年 | 72篇 |
1994年 | 68篇 |
1993年 | 88篇 |
1992年 | 200篇 |
1991年 | 193篇 |
1990年 | 201篇 |
1989年 | 185篇 |
1988年 | 176篇 |
1987年 | 169篇 |
1986年 | 167篇 |
1985年 | 168篇 |
1984年 | 124篇 |
1983年 | 110篇 |
1982年 | 89篇 |
1981年 | 86篇 |
1980年 | 73篇 |
1979年 | 76篇 |
1978年 | 85篇 |
1976年 | 62篇 |
1974年 | 74篇 |
1973年 | 60篇 |
1971年 | 68篇 |
Purpose
Work-related eye injuries have been reported with a variety of epidemiologic and clinical characteristics. We aimed to identify epidemiologic characteristics of work-related eye injuries and risk factors associated with severe injury in a large metropolitan city. 相似文献Background
Rosacea is a chronic inflammatory skin condition whose etiology has been linked to mast cells and the antimicrobial peptide cathelicidin LL-37. Individuals with refractory disease have demonstrated clinical benefit with periodic injections of onabotulinum toxin, but the mechanism of action is unknown.Objectives
To investigate the molecular mechanism by which botulinum toxin improves rosacea lesions.Methods
Primary human and murine mast cells were pretreated with onabotulinum toxin A or B or control. Mast cell degranulation was evaluated by β-hexosaminidase activity. Expression of botulinum toxin receptor Sv2 was measured by qPCR. The presence of SNAP-25 and VAMP2 was established by immunofluorescence. In vivo rosacea model was established by intradermally injecting LL-37 with or without onabotulinum toxin A pretreatment. Mast cell degranulation was assessed in vivo by histologic counts. Rosacea biomarkers were analyzed by qPCR of mouse skin sections.Results
Onabotulinum toxin A and B inhibited compound 48/80-induced degranulation of both human and murine mast cells. Expression of Sv2 was established in mouse mast cells. Onabotulinum toxin A and B increased cleaved SNAP-25 and decreased VAMP2 staining in mast cells respectively. In mice, injection of onabotulinum toxin A significantly reduced LL-37-induced skin erythema, mast cell degranulation, and mRNA expression of rosacea biomarkers.Conclusions
These findings suggest that onabotulinum toxin reduces rosacea-associated skin inflammation by directly inhibiting mast cell degranulation. Periodic applications of onabotulinum toxin may be an effective therapy for refractory rosacea and deserves further study. 相似文献Material and methods: original research studies were searched from seven databases (MEDLINE, EMBASE, CENTRAL, CINAHL, SCOPUS, PEDro and PubMed). Subsequently, two independent reviewers screened the titles and abstracts followed by full-text reviews to assess the studies' eligibility.
Results: eleven studies met the inclusion criteria and had data abstracted and quality assessed. Methodology varied considerably and yet cognitive tasks resulted in the ΔO2Hb increasing in 8 of the 11 and ΔHHb decreasing in 8 of 8 studies that reported this outcome. The cognitive tasks from 10 of the 11 studies were classified as “Working Memory” and “Verbal Fluency Tasks”.
Conclusions: although, the data comparison was challenging provided the heterogeneity in methodology, the results across studies were similar. 相似文献